We are live on ! Find out more
Ray Dalio

Ray Dalio Bridgewater Associates

AUM $22.4B
1-Year Est. Return 34.48%
 

Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.

This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+34.48%
3 Year Est. Return
+84.29%
5 Year Est. Return
+89.92%
10 Year Est. Return
+230.06%
AUM
$10.5B
AUM Growth
+$371M
Cap. Flow
+$653M
Cap. Flow %
6.2%
Top 10 Hldgs %
83.17%
Holding
377
New
78
Increased
101
Reduced
85
Closed
110

Sector Composition

Rank Sector Weight
1 Energy 2.75%
2 Technology 2.62%
3 Consumer Discretionary 2.44%
4 Financials 1.98%
5 Healthcare 1.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNKD
376
DELISTED
LinkedIn Corporation
LNKD
-1,200
Closed -$229K
DO
377
DELISTED
Diamond Offshore Drilling
DO
-425,690
Closed -$7.5M

Similar funds

Ray Dalio's Q4 2016 Portfolio in Review

As of Q4 2016, Ray Dalio held 377 positions worth $10.5B, up 3.7% from $10.2B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Ray Dalio deployed $653M of net new capital in Q4 2016, opening 78 new positions and adding to 101 existing holdings. Its largest new stake was UnitedHealth: 163,900 shares worth $26.2M.

By sector, the portfolio is most concentrated in Energy at 2.8% of assets, down from 2.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $172M trimmed.

  • Ray Dalio's largest Q4 2016 buy was UnitedHealth: 163,900 shares worth $26.2M.
  • Ray Dalio added most to Vanguard FTSE Emerging Markets ETF in Q4 2016, an estimated $432M increase.
  • Ray Dalio's biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $172M.
  • Ray Dalio fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $21.1M.
  • Ray Dalio's ten largest holdings make up 83% of its $10.5B portfolio in Q4 2016.
  • Ray Dalio opened 78 new positions and closed 110 in Q4 2016.
  • Ray Dalio's portfolio value rose 3.7% quarter-over-quarter to $10.5B.

Based on Bridgewater Associates's 13F filing for Q4 2016, filed 10 Feb 2017.